Symbol
PTIX on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
240,000 shares
Security Ownership %
3.4%

Armistice Capital, LLC ownership in Protagenic Therapeutics, Inc.\new Common Stock, par value $0.0001 per share (PTIX)

14 Feb 2025 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 240,000 shares of Protagenic Therapeutics, Inc.\new Common Stock, par value $0.0001 per share (PTIX). This represents 3.4% ownership of the company. This is the first filing by ARMISTICE CAPITAL, LLC disclosing ownership of Protagenic Therapeutics, Inc.\new Common Stock, par value $0.0001 per share (PTIX).